Breaking News Instant updates and real-time market news.

BOX

Box

$23.43 /

-0.63 (-2.62%)

, DOCU

DocuSign

$306.70 /

-1.79 (-0.58%)

14:18
07/26/21
07/26
14:18
07/26/21
14:18

Box rolls out native e-signature capability with Box Sign

Box (BOX) began rolling out Box Sign, its native e-signature capability, to customers on Business and Enterprise plans at no additional cost. With Monday's launch, Box Sign delivers unlimited signatures and a robust set of APIs, enabling businesses to digitize and modernize the way agreements are managed and governed in the cloud. Following the rollout of Box Sign, basic functionality will be included in all Box business plans and advanced features that help automate high-volume, complex e-signature use cases will be available in higher-tier plans. In February, Box acquired SignRequest, a leading cloud-based electronic signature company, and developed Box Sign on its industry-leading technology. Natively integrated into Box, this new capability reduces business costs for third-party e-signature tools while enhancing team and individual productivity. "Every day, more transactions are moving from paper-based manual workflows to the cloud, and we will only see this trend accelerate as companies shift to a hybrid work environment," said Diego Dugatkin, Chief Product Officer at Box. "With the addition of natively embedded e-signatures, Box customers will be able to manage the entire content lifecycle in the cloud, realizing the value of their content - at no additional cost. From the moment a file is created to when it's shared, edited, published, approved, signed, classified, and retained, the entire content lifecycle can now happen in the Box Content Cloud." The Fly notes that DocuSign (DOCU) has a similar offering.

BOX

Box

$23.43 /

-0.63 (-2.62%)

DOCU

DocuSign

$306.70 /

-1.79 (-0.58%)

  • 09

    Sep

BOX Box
$23.43 /

-0.63 (-2.62%)

07/21/21 RBC Capital
Box initiated with an Underperform at RBC Capital
04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
DOCU DocuSign
$306.70 /

-1.79 (-0.58%)

07/09/21 Piper Sandler
DocuSign price target raised to $330 from $300 at Piper Sandler
06/18/21 Wedbush
DocuSign price target raised to $290 from $260 at Wedbush
06/10/21 RBC Capital
DocuSign assumed with an Outperform at RBC Capital
06/04/21 Wedbush
DocuSign price target lowered to $260 from $300 at Wedbush

TODAY'S FREE FLY STORIES

Hot Stocks
Enthusiast Gaming announces updates for Addicting Games » 07:38
10/21/21
10/21
07:38
10/21/21
07:38
EGLX

Enthusiast Gaming

$3.52 /

-0.085 (-2.36%)

Enthusiast Gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGLX Enthusiast Gaming
$3.52 /

-0.085 (-2.36%)

EGLX Enthusiast Gaming
$3.52 /

-0.085 (-2.36%)

10/01/21 RBC Capital
Enthusiast Gaming initiated with an Outperform at RBC Capital
07/29/21 Scotiabank
Enthusiast Gaming initiated with an Outperform at Scotiabank
06/23/21 H.C. Wainwright
Enthusiast Gaming initiated with a Buy at H.C. Wainwright
  • 11
    Jun
EGLX Enthusiast Gaming
$3.52 /

-0.085 (-2.36%)

Recommendations
Qualtrics price target raised to $55 from $45 at Raymond James » 07:38
10/21/21
10/21
07:38
10/21/21
07:38
XM

Qualtrics

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XM Qualtrics
/

+

XM Qualtrics
/

+

07:09 Today Deutsche Bank
Qualtrics price target raised to $48 from $45 at Deutsche Bank
06:51 Today BMO Capital
Qualtrics price target raised to $53 from $46 at BMO Capital
06:20 Today JMP Securities
Qualtrics price target raised to $59 from $55 at JMP Securities
04:46 Today Oppenheimer
Qualtrics price target raised to $60 from $55 at Oppenheimer
XM Qualtrics
/

+

  • 28
    Jan
XM Qualtrics
/

+

XM Qualtrics
/

+

XM Qualtrics
/

+

Recommendations
Tesla 20M delivery target 'extreme blue sky scenario,' says JPMorgan » 07:38
10/21/21
10/21
07:38
10/21/21
07:38
TSLA

Tesla

$865.75 /

+2.25 (+0.26%)

JPMorgan analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

07:32 Today Bernstein
Bernstein keeps Underperform rating on Tesla following 'solid' Q3 results
07:06 Today Deutsche Bank
Tesla price target raised to $1,000 from $900 at Deutsche Bank
07:06 Today Baird
Tesla price target raised to $888 from $764 at Baird
06:48 Today Mizuho
Tesla price target raised to $950 from $825 at Mizuho
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

Upgrade
Centerra Gold upgraded to Buy from Speculative Buy at Canaccord » 07:37
10/21/21
10/21
07:37
10/21/21
07:37
CGAU

Centerra Gold

$7.89 /

+0.31 (+4.09%)

Canaccord analyst Dalton…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGAU Centerra Gold
$7.89 /

+0.31 (+4.09%)

CGAU Centerra Gold
$7.89 /

+0.31 (+4.09%)

10/13/21 Raymond James
Centerra Gold price target lowered to C$10.50 from C$11 at Raymond James
09/10/21 National Bank
Centerra Gold price target raised to C$12 from C$11.50 at National Bank
08/11/21 CIBC
Centerra Gold upgraded to Neutral from Underperformer at CIBC
07/16/21 National Bank
Centerra Gold price target raised to C$11.50 from C$11.25 at National Bank
CGAU Centerra Gold
$7.89 /

+0.31 (+4.09%)

CGAU Centerra Gold
$7.89 /

+0.31 (+4.09%)

Hot Stocks
Frequency Therapeutics says 1st patient dosed in FX-322 Phase 2b SNHL study » 07:37
10/21/21
10/21
07:37
10/21/21
07:37
FREQ

Frequency Therapeutics

$6.87 /

+0.015 (+0.22%)

Frequency Therapeutics, …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FREQ Frequency Therapeutics
$6.87 /

+0.015 (+0.22%)

FREQ Frequency Therapeutics
$6.87 /

+0.015 (+0.22%)

09/22/21 Goldman Sachs
Frequency Therapeutics downgraded to Neutral from Buy at Goldman Sachs
05/17/21 B. Riley
Frequency Therapeutics price target lowered to $21 from $35 at B. Riley
03/24/21 B. Riley Securities
Frequency Therapeutics price target lowered to $35 from $79 at B. Riley
03/24/21 Oppenheimer
Frequency Therapeutics price target lowered to $20 from $68 at Oppenheimer
FREQ Frequency Therapeutics
$6.87 /

+0.015 (+0.22%)

Recommendations
Biogen price target lowered to $502 from $647 at Truist » 07:37
10/21/21
10/21
07:37
10/21/21
07:37
BIIB

Biogen

$266.28 /

-1.53 (-0.57%)

Truist analyst Robyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

06:54 Today Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/20/21 Piper Sandler
Biogen price target lowered to $390 from $460 at Piper Sandler
10/20/21 Piper Sandler
Biogen's Aduhelm launch 'even worse than feared,' says Piper Sandler
10/17/21 Piper Sandler
Piper Sandler remains bullish on Biogen despite mixed VALOR study update
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

Recommendations
Brinker price target lowered to $48 from $65 at Wells Fargo » 07:37
10/21/21
10/21
07:37
10/21/21
07:37
EAT

Brinker

$44.24 /

-4.68 (-9.57%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

07:28 Today JPMorgan
Brinker selloff brings 'right entry' point, says JPMorgan
06:59 Today Stephens
Stephens remains buyer of Brinker, sees shares at trough
10/19/21 Stephens
Brinker margin miss even larger than expected, says Stephens
10/18/21 KeyBanc
Brinker price target lowered to $58 from $63 at KeyBanc
EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

Recommendations
North American Construction price target raised to C$28 from C$25 » 07:36
10/21/21
10/21
07:36
10/21/21
07:36
NOA

North American Construction

$16.65 /

+0.26 (+1.59%)

Canaccord analyst Yuri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOA North American Construction
$16.65 /

+0.26 (+1.59%)

NOA North American Construction
$16.65 /

+0.26 (+1.59%)

07/30/21 National Bank
North American Construction price target raised to C$25 from C$24 at National Bank
06/22/21 Raymond James
North American Construction price target raised to C$24 at Raymond James
06/22/21 BMO Capital
North American Construction price target raised to C$24 at BMO Capital
06/22/21 TD Securities
North American Construction price target raised to C$21 at TD Securities
NOA North American Construction
$16.65 /

+0.26 (+1.59%)

Hot Stocks
BioCardia announces first patient treated in CardiAMP Cell Therapy trial » 07:36
10/21/21
10/21
07:36
10/21/21
07:36
BCDA

BioCardia

$2.94 /

-0.02 (-0.68%)

BioCardia announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$2.94 /

-0.02 (-0.68%)

BCDA BioCardia
$2.94 /

-0.02 (-0.68%)

04/16/21 Dawson James
Dawson James downgrades BioCardia, sees capital raise this year
04/16/21 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
BCDA BioCardia
$2.94 /

-0.02 (-0.68%)

Hot Stocks
Business First Bancshares, Texas Citizens Bancorp announce merger » 07:36
10/21/21
10/21
07:36
10/21/21
07:36
BFST

Business First Bancshares

$25.60 /

+0.365 (+1.45%)

Business First Bancshares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BFST Business First Bancshares
$25.60 /

+0.365 (+1.45%)

05/20/21 DA Davidson
Business First Bancshares upgraded to Buy from Neutral at DA Davidson
BFST Business First Bancshares
$25.60 /

+0.365 (+1.45%)

Earnings
City Holding reports Q3 EPS $1.47, consensus $1.24 » 07:35
10/21/21
10/21
07:35
10/21/21
07:35
CHCO

City Holding

$78.00 /

+0.76 (+0.98%)

"While consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHCO City Holding
$78.00 /

+0.76 (+0.98%)

Hot Stocks
Intellia Therapeutics receives US FDA orphan drug designation for NTLA-2001 » 07:35
10/21/21
10/21
07:35
10/21/21
07:35
NTLA

Intellia Therapeutics

$128.94 /

-3.94 (-2.97%)

Intellia Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$128.94 /

-3.94 (-2.97%)

NTLA Intellia Therapeutics
$128.94 /

-3.94 (-2.97%)

10/05/21 Guggenheim
Intellia Therapeutics initiated with a Buy at Guggenheim
09/23/21 Stifel
Intellia Therapeutics initiated with a Buy at Stifel
08/06/21 Raymond James
Intellia Therapeutics price target raised to $181 from $168 at Raymond James
08/05/21 Chardan
Intellia Therapeutics price target raised to $177 from $130 at Chardan
NTLA Intellia Therapeutics
$128.94 /

-3.94 (-2.97%)

  • 30
    Jun
  • 02
    Dec
NTLA Intellia Therapeutics
$128.94 /

-3.94 (-2.97%)

Recommendations
Abbott price target raised to $134 from $128 at Raymond James » 07:34
10/21/21
10/21
07:34
10/21/21
07:34
ABT

Abbott

$123.32 /

+3.94 (+3.30%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$123.32 /

+3.94 (+3.30%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

10/14/21 Redburn
Abbott initiated with a Neutral at Redburn
10/04/21 Cowen
Abbott Q3 results not likely to contain sales warning, says at Cowen
10/01/21 Citi
Abbott price target raised to $140 from $135 at Citi
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
ABT Abbott
$123.32 /

+3.94 (+3.30%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

ABT Abbott
$123.32 /

+3.94 (+3.30%)

Downgrade
Great Bear Royalties downgraded to Hold from Buy at Canaccord » 07:34
10/21/21
10/21
07:34
10/21/21
07:34
GBRBF

Great Bear Royalties

$4.80 /

-0.18268 (-3.67%)

Canaccord analyst Carey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBRBF Great Bear Royalties
$4.80 /

-0.18268 (-3.67%)

08/24/21 Canaccord
Great Bear Royalties initiated with a Speculative Buy at Canaccord
Recommendations
Las Vegas Sands price target lowered to $42 from $50 at Wells Fargo » 07:34
10/21/21
10/21
07:34
10/21/21
07:34
LVS

Las Vegas Sands

$39.57 /

-0.735 (-1.82%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

07:10 Today Stifel
Las Vegas Sands should 'take a stand' with 'aggressive' buybacks, says Stifel
06:00 Today Citi
Las Vegas Sands price target lowered to $58.50 from $61 at Citi
05:43 Today Deutsche Bank
Las Vegas Sands price target lowered to $65 from $73 at Deutsche Bank
09/28/21 Citi
Las Vegas Sands price target lowered to $61 from $80 at Citi
LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

LVS Las Vegas Sands
$39.57 /

-0.735 (-1.82%)

Hot Stocks
CI Financial to acquire McCutchen Group, terms undisclosed » 07:34
10/21/21
10/21
07:34
10/21/21
07:34
CIXX

CI Financial

$22.66 /

+0.15 (+0.67%)

CI Financial and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIXX CI Financial
$22.66 /

+0.15 (+0.67%)

CIXX CI Financial
$22.66 /

+0.15 (+0.67%)

08/12/21 Desjardins
CI Financial price target raised to C$29 from C$27 at Desjardins
08/11/21 BMO Capital
CI Financial price target raised to C$30 from C$26 at BMO Capital
08/11/21 RBC Capital
CI Financial price target raised to C$30 from C$26 at RBC Capital
08/11/21 TD Securities
CI Financial price target raised to C$28 from C$26 at TD Securities
CIXX CI Financial
$22.66 /

+0.15 (+0.67%)

Earnings
Pool Corp. raises FY21 EPS guidance to $14.85-$15.35 from $13.75-$14.25 » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
POOL

Pool Corp.

$463.54 /

-1.06 (-0.23%)

FY21 EPS consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

07/23/21 Loop Capital
Pool Corp. price target raised to $485 from $470 at Loop Capital
07/23/21 Baird
Pool Corp. price target raised to $490 from $465 at Baird
06/04/21 Loop Capital
Pool Corp. price target raised to $470 from $440 at Loop Capital
05/18/21
Fly Intel: Top five analyst initiations
POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

Earnings
Webster Financial reports Q3 EPS $1.03 with items, consensus $1.08 » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
WBS

Webster Financial

$58.62 /

+1.71 (+3.00%)

Q3 EPS would have been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WBS Webster Financial
$58.62 /

+1.71 (+3.00%)

WBS Webster Financial
$58.62 /

+1.71 (+3.00%)

07/23/21 Wedbush
Webster Financial price target lowered to $60 from $65 at Wedbush
06/03/21 Raymond James
Webster Financial price target raised to $64 from $59 at Raymond James
05/10/21 Stephens
Dime Community upgraded to Overweight at Stephens following 'solid' Q1
04/22/21
Fly Intel: Top five analyst upgrades
Earnings
Safehold reports Q3 EPS 38c, consensus 35c » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
SAFE

Safehold

$75.62 /

+0.3 (+0.40%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAFE Safehold
$75.62 /

+0.3 (+0.40%)

SAFE Safehold
$75.62 /

+0.3 (+0.40%)

09/21/21
Safehold files to sell 2M shares and concurrent private placement
07/30/21 Truist
Safehold price target raised to $80 from $72 at Truist
07/27/21 B. Riley
Safehold price target raised to $110 from $100 at B. Riley
07/22/21 Truist
Truist 'not overly concerned' by Safehold earnings miss
SAFE Safehold
$75.62 /

+0.3 (+0.40%)

  • 23
    Sep
  • 11
    Nov
SAFE Safehold
$75.62 /

+0.3 (+0.40%)

Hot Stocks
Roku tells customers it is unable to strike a deal with YouTube » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
ROKU

Roku

$338.82 /

-5.42 (-1.57%)

, GOOG

Alphabet

$2,849.95 /

-26.54 (-0.92%)

, GOOGL

Alphabet Class A

$2,834.23 /

-29.28 (-1.02%)

Roku (ROKU) told…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$338.82 /

-5.42 (-1.57%)

GOOG Alphabet
$2,849.95 /

-26.54 (-0.92%)

GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

ROKU Roku
$338.82 /

-5.42 (-1.57%)

10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
09/30/21 Cleveland Research
Roku initiated with a Buy at Cleveland Research
09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/24/21
Fly Intel: Top five analyst downgrades
GOOG Alphabet
$2,849.95 /

-26.54 (-0.92%)

06:42 Today Mizuho
Alphabet price target raised to $3,100 from $3,000 at Mizuho
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

06:42 Today Mizuho
Alphabet price target raised to $3,100 from $3,000 at Mizuho
10/20/21 Barclays
Zoom Video initiated with an Equal Weight at Barclays
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Credit Suisse remains bullish on Alphabet ahead of quarterly results
ROKU Roku
$338.82 /

-5.42 (-1.57%)

GOOG Alphabet
$2,849.95 /

-26.54 (-0.92%)

GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

ROKU Roku
$338.82 /

-5.42 (-1.57%)

GOOG Alphabet
$2,849.95 /

-26.54 (-0.92%)

GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

ROKU Roku
$338.82 /

-5.42 (-1.57%)

GOOG Alphabet
$2,849.95 /

-26.54 (-0.92%)

GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

ROKU Roku
$338.82 /

-5.42 (-1.57%)

GOOGL Alphabet Class A
$2,834.23 /

-29.28 (-1.02%)

Upgrade
Franco-Nevada upgraded to Buy from Hold at Canaccord » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
FNV

Franco-Nevada

$140.67 /

-0.03 (-0.02%)

Canaccord analyst Carey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FNV Franco-Nevada
$140.67 /

-0.03 (-0.02%)

FNV Franco-Nevada
$140.67 /

-0.03 (-0.02%)

09/24/21 KeyBanc
Franco-Nevada initiated with an Overweight at KeyBanc
09/10/21 National Bank
Franco-Nevada price target lowered to C$200 from C$205 at National Bank
07/16/21 National Bank
Franco-Nevada price target raised to C$205 from C$200 at National Bank
07/16/21 Canaccord
Franco-Nevada downgraded to Hold from Buy at Canaccord
FNV Franco-Nevada
$140.67 /

-0.03 (-0.02%)

FNV Franco-Nevada
$140.67 /

-0.03 (-0.02%)

Recommendations
Ferrari price target raised to $215 from $189 at JPMorgan » 07:33
10/21/21
10/21
07:33
10/21/21
07:33
RACE

Ferrari

/

+

JPMorgan analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RACE Ferrari
/

+

RACE Ferrari
/

+

09/16/21 Exane BNP Paribas
Ferrari cut to Neutral at Exane BNP Paribas on slow cyclical recovery
09/16/21 Exane BNP Paribas
Ferrari downgraded to Neutral from Outperform at Exane BNP Paribas
09/15/21 BofA
BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy
09/09/21 Oddo BHF
Ferrari initiated with an Outperform at Oddo BHF
RACE Ferrari
/

+

RACE Ferrari
/

+

RACE Ferrari
/

+

Recommendations
Bernstein keeps Underperform rating on Tesla following 'solid' Q3 results » 07:32
10/21/21
10/21
07:32
10/21/21
07:32
TSLA

Tesla

$865.75 /

+2.25 (+0.26%)

Bernstein analyst Toni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

07:06 Today Deutsche Bank
Tesla price target raised to $1,000 from $900 at Deutsche Bank
07:06 Today Baird
Tesla price target raised to $888 from $764 at Baird
06:48 Today Mizuho
Tesla price target raised to $950 from $825 at Mizuho
06:43 Today BofA
Tesla price target raised to $1,000 from $900 at BofA
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

Hot Stocks
Matinas BioPharma initiates dosing in Phase 1 study of MAT2501 » 07:32
10/21/21
10/21
07:32
10/21/21
07:32
MTNB

Matinas BioPharma

$1.14 /

-0.02 (-1.73%)

Matinas BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTNB Matinas BioPharma
$1.14 /

-0.02 (-1.73%)

MTNB Matinas BioPharma
$1.14 /

-0.02 (-1.73%)

09/13/21 Piper Sandler
Matinas' next steps for MAT2203 'still unclear,' says Piper Sandler
05/11/21 Piper Sandler
Matinas BioPharma downgraded to Neutral from Overweight at Piper Sandler
03/30/21 H.C. Wainwright
Matinas BioPharma price target lowered to $3 from $4 at H.C. Wainwright
02/01/21 Piper Sandler
Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
MTNB Matinas BioPharma
$1.14 /

-0.02 (-1.73%)

MTNB Matinas BioPharma
$1.14 /

-0.02 (-1.73%)

Recommendations
General Motors price target raised to $80 from $77 at JPMorgan » 07:32
10/21/21
10/21
07:32
10/21/21
07:32
GM

General Motors

$57.66 /

+0.81 (+1.42%)

JPMorgan analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$57.66 /

+0.81 (+1.42%)

GM General Motors
$57.66 /

+0.81 (+1.42%)

10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
10/15/21 Tigress Financial
General Motors shares going to $86 in 12 months, says Tigress Financial
10/11/21 Citi
GM's 2030 outlook supports $200 sum-of-the-parts stock price, says Citi
10/08/21 Citi
Citi 'gained meaningful conviction' in thesis GM shares topping $100
GM General Motors
$57.66 /

+0.81 (+1.42%)

GM General Motors
$57.66 /

+0.81 (+1.42%)

GM General Motors
$57.66 /

+0.81 (+1.42%)

GM General Motors
$57.66 /

+0.81 (+1.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.